Literature DB >> 2412208

Novel deletion mutants that enhance a distant upstream 5' splice in the E3 transcription unit of adenovirus 2.

S L Deutscher, B M Bhat, M H Pursley, C Cladaras, W S Wold.   

Abstract

Region E3 of adenovirus is a "complex" transcription unit: i.e. different mRNAs and proteins arise by differential RNA 3' end selection and differential splicing of the primary transcript. We are using viable virus mutants to understand the controls that dictate the specificity and efficiency of the RNA processing signals. We describe a novel class of deletion mutations that enhance a natural 5' splice site located approximately 740 nucleotides (nt) upstream. In particular, deletions within nt 1691-2044 in the E3 transcription unit result in a 5-fold enhancement of the 5' splice site at nt 951 (as reflected in steady-state mRNA). The effect is specific, because the deletions do not affect the 5' splice site at nt 372, and because deletions within nt 2044-2214 do not affect either the 951 or the 372 5' splice sites. As a consequence of the enhanced splicing at the 951 5' site, synthesis of the major E3 mRNA and the major E3 protein (gp19K) are dramatically reduced. At least one of the natural 3' splice sites, located at nt 2157, is the recipient of the enhanced splicing at the 951 5' splice site. We conclude that sequences located within nt 1691-2044 affect (probably in cis) splicing at the 951 5' splice site. We speculate that nt 1691-2044 includes a splicing control region which functions to suppress splicing at the 951 5' splice site.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412208      PMCID: PMC321911          DOI: 10.1093/nar/13.16.5771

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  46 in total

1.  Complex splicing patterns of RNAs from the early regions of adenovirus-2.

Authors:  L T Chow; T R Broker; J B Lewis
Journal:  J Mol Biol       Date:  1979-10-25       Impact factor: 5.469

Review 2.  Variety in the level of gene control in eukaryotic cells.

Authors:  J E Darnell
Journal:  Nature       Date:  1982-06-03       Impact factor: 49.962

3.  DNA sequences affecting specific initiation of transcription in vitro from the EIII promoter of adenovirus 2.

Authors:  D C Lee; R G Roeder; W S Wold
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

4.  Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome.

Authors:  J Hérissé; G Courtois; F Galibert
Journal:  Nucleic Acids Res       Date:  1980-05-24       Impact factor: 16.971

5.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Synthesis and genomic site for an adenovirus type 2 early glycoprotein.

Authors:  H Persson; M Jansson; L Philipson
Journal:  J Mol Biol       Date:  1980-02-05       Impact factor: 5.469

8.  New chimeric splice junction in adenovirus type 2-simian virus 40 hybrid viral mRNA.

Authors:  G Khoury; J Alwine; N Goldman; P Gruss; G Jay
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

9.  A gene chimaera of SV40 and mouse beta-globin is transcribed and properly spliced.

Authors:  G Chu; P A Sharp
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

10.  Multiple mRNA species for the precursor to an adenovirus-encoded glycoprotein: identification and structure of the signal sequence.

Authors:  H Persson; H Jörnvall; J Zabielski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more
  17 in total

1.  Mutations within the ADP (E3-11.6K) protein alter processing and localization of ADP and the kinetics of cell lysis of adenovirus-infected cells.

Authors:  Ann E Tollefson; Abraham Scaria; Baoling Ying; William S M Wold
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

2.  Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus.

Authors:  H A Brady; A Scaria; W S Wold
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  The 11,600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection.

Authors:  A E Tollefson; A Scaria; S K Saha; W S Wold
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus.

Authors:  A E Tollefson; P Krajcsi; S P Yei; C R Carlin; W S Wold
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus.

Authors:  H A Brady; W S Wold
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

6.  A small deletion distant from a splice or polyadenylation site dramatically alters pre-mRNA processing in region E3 of adenovirus.

Authors:  B M Bhat; W S Wold
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  Competition between splicing and polyadenylation reactions determines which adenovirus region E3 mRNAs are synthesized.

Authors:  H A Brady; W S Wold
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

8.  Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants.

Authors:  B M Bhat; W S Wold
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

9.  Adenovirus mutants with splice-enhancing mutations in the E3 complex transcription unit are also defective in E3A RNA 3'-end formation.

Authors:  B M Bhat; W S Wold
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

10.  The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells.

Authors:  A E Tollefson; A Scaria; T W Hermiston; J S Ryerse; L J Wold; W S Wold
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.